Other Guidelines | Page 27 | European Cystic Fibrosis Society (ECFS)

Current Prices versus Minimum Costs of Production for CFTR Modulators

Evaluation of a novel compound, AZD5634, in healthy volunteers and patients with cystic fibrosis

Evaluation of a biochemical cystic fibrosis newborn screening protocol using IRT and PAP

Comparing four different definitions of chronic pseudomonas infection in people with cystic fibrosis

How does chronic rhinosinusitis impact quality of life of cystic fibrosis patients?

Drug levels and dosing recommendations for antibiotics used to treat Mycobacterium avium complex in people with cystic fibrosis.

Cystic fibrosis liver disease – A clinical challenge in the era of improved outcomes.

A microengineered laboratory model of human CF lung

Serodiagnostic as a complement to bacterial culture in identification of Mycobacterium abscessus infections in cystic fibrosis patients

Changes in inpatient episodes following the introduction of modulator therapy across different age groups in the USA

first
previous
…
23
24
25
26
27
28
29
30
31
…
next
last